Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GW's finance chief resigns

This article was originally published in Scrip

Executive Summary

GW Pharmaceuticals announced that, after ten years as finance director, David Kirk has informed the company that he intends to stand down from the Board on 1 June 2012. Mr Kirk will be succeeded by Adam David George, who has served as GW’s company secretary and group financial controller since 2007. Mr Kirk will continue to be available to the company in a consulting capacity for an agreed period of time.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC016879

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel